Tuesday, March 4, 2025
spot_img

Danske Bank share buy-back programme: transactions in week 9

 

Company announcement no. 10 2025

Danske Bank

Bernstorffsgade 40

DK-1577 København V

Tel. + 45 33 44 00 00

03/03/2025

Page 1 of 1

Danske Bank share buy-back programme: transactions in week 9

On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at the latest, as described in company announcement no. 6 2025.

The Programme is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”).

The following transactions on Nasdaq Copenhagen A/S were made under the share buy-back programme in week 9:

  Number of shares VWAP DKK Gross value DKK
Accumulated, last announcement 50,000 233.7298 11,686,490
24/02/2025 5,000 235.6691 1,178,346
25/02/2025 5,000 236.7242 1,183,621
26/02/2025 5,000 241.9445 1,209,723
27/02/2025 5,000 243.3454 1,216,727
28/02/2025 5,000 241.1500 1,205,750
Total accumulated over week 9 25,000 239.7666 5,994,166
Total accumulated during the share buyback programme 75,000 235.7421 17,680,656

With the transactions stated above, the total accumulated number of own shares under the share buy-back programme corresponds to 0.009% of Danske Bank A/S’ share capital.

Danske Bank

Contact: Claus Ingar Jensen, Head of Group Investor Relations, tel. +45 25 42 43 70

Attachment

  • Danske Bank Template Company announcementUK

Powered by SlickText.com

Hot this week

Tenaya Therapeutics Announces Pricing of Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 ...

Gencor Announces Preliminary Unaudited Results

ORLANDO, Fla., March 03, 2025 (GLOBE NEWSWIRE)...

Tenaya Therapeutics Announces Proposed Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 ...

The Ensign Group Continues Growth in Arizona

SAN JUAN CAPISTRANO, Calif., March 03, 2025 ...

Topics

Tenaya Therapeutics Announces Pricing of Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 ...

Gencor Announces Preliminary Unaudited Results

ORLANDO, Fla., March 03, 2025 (GLOBE NEWSWIRE)...

Tenaya Therapeutics Announces Proposed Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 ...

The Ensign Group Continues Growth in Arizona

SAN JUAN CAPISTRANO, Calif., March 03, 2025 ...

Dave Reports Fourth Quarter & Full Year 2024 Financial Results

Record Q4 Revenue up 38% Y/Y to $100.9 Million;...
spot_img

Related Articles

Popular Categories

spot_img